GROUPE TECHNOLOGIQUE KDA ANNOUNCES A STRATEGIC COLLABORATION WITH PHARMACIE HORIZON SANTÉ AND DR. ÉRIC POIRIER TO OPTIMIZE ONCOLOGY TREATMENT MANAGEMENT

Stock Information for F3 Uranium Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About F3 Uranium Corp.

KDA GROUP ANNOUNCES PARTNERSHIP AGREEMENT WITH CHU DE QUÉBEC-UNIVERSITÉ LAVAL FOR THE DEPLOYMENT OF MEDHERIZE
KDA GROUP DEPLOYS MEDHERIZE ACROSS COMMUNITY PHARMACIES: A MAJOR STEP FORWARD IN THE MANAGEMENT OF ORAL ANTICANCER THERAPIES
KDA GROUP ANNOUNCES AGREEMENT TO ACQUIRE MINORITY INTEREST IN ITS SUBSIDIARY GROUPE TECHNOLOGIQUE KDA INC.
KDA GROUP OPENS A U.S. SUBSIDIARY AND ACCELERATES THE GROWTH OF ITS MEDHERIZE SOLUTION
KDA GROUP ANNOUNCES CLOSING OF PRIVATE PLACEMENT
KDA GROUP RECEIVES DSQ CERTIFICATION FOR ADHERIZE+ PLATFORM -- MEDHERIZE MODULE ENTERS CLINICAL DEPLOYMENT PHASE
KDA GROUP REACHES FINAL CERTIFICATION PHASE FOR MEDHERIZE WITH DSQ - DOSSIER SANTÉ QUÉBEC
KDA GROUP ANNOUNCES RESULTS OF SHAREHOLDERS' ANNUAL GENERAL MEETING

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.